Xtacy Therapeutics (TSE:XTCY) has released an update.
Xtacy Therapeutics Corp. has announced that it will strengthen its financial position by issuing 3,580,500 common shares to settle CA$179,025 of debt owed to various creditors. The shares, priced at $0.05 each, will be subject to a four-month statutory hold period following issuance. This strategic move is aimed at reducing the company’s liabilities and improving its financial stability.
For further insights into TSE:XTCY stock, check out TipRanks’ Stock Analysis page.
